Disease/Infection News

RSS

Two studies set groundwork for new avenues to treat influenza and anthrax poisoning

Two recent studies led by biologists at the University of California San Diego have set the research groundwork for new avenues to treat influenza and anthrax poisoning

17 Oct 2017

Study opens door to new approach for curing HIV infections

In findings that open the door to a completely different approach to curing HIV infections, scientists from the Florida campus of The Scripps Research Institute have for the first time shown that a novel compound effectively suppresses production of the virus in chronically infected cells, and prevents viral rebound, even when those infected cells are subjected to vigorous stimulation.

17 Oct 2017

Plague outbreak in Madagascar kills 57 and rages on

The plague outbreak in Madagascar is killing scores of people and affecting hundreds. Last estimated on the 12th of October 2017, there are 57 reported deaths due to the disease with 680 down with the infection. Of these 25 deaths and 329 cases are from the capital city of Antananarivo.

16 Oct 2017

Portable scanner can measure limb disfigurement easily in patients with elephantiasis

An estimated 120 million people worldwide are infected with lymphatic filariasis, a parasitic, mosquito-borne disease that can cause major swelling and deformity of the legs, a condition known as elephantiasis.

16 Oct 2017

IGeneX launches three new tests to aid diagnosis of Borreliosis

IGeneX Inc., a CLIA and New York-approved Reference Laboratory, specializing in testing for tick-borne diseases, is pleased to announce the launch of three new tests that are more inclusive and specific for aiding in diagnosis of Borreliosis (Lyme Disease and Tick-Borne Relapsing Fever, Borreliosis).

16 Oct 2017

Report sheds light on global market for infectious disease immunoassays

Kalorama Information says that infectious disease immunoassays beat the IVD market and the overall IVD market in terms of revenue growth. Immunoassays are tests that are based on the binding of antibodies to antigens to identify the presence of a substance.

16 Oct 2017

Endogenous infection marker can help guide antibiotic use

The endogenous infection marker procalcitonin can help to guide the use of antibiotics when treating infections. The course of antibiotic therapy is shortened, and its side effects and mortality rate also decrease, as researchers from the University of Basel and other colleagues report in the journal The Lancet Infectious Diseases.

16 Oct 2017

UAB expert provides in-depth understanding of food-borne illnesses

Parties and gatherings are typically centered around food, making it important to know the do's and don'ts of handling food.

13 Oct 2017

NTNU researchers reveal how HCV converts innocent cells into virus factories

The Hepatitis C (HCV) virus is a sly enemy to have in one's body. Not only does it manage to make itself invisible to the immune system by breaking down communication between the immune cells, it also builds secret virus "factories" that quickly go into mass production.

13 Oct 2017

Academy of Medical Sciences announces new UK-India scheme to address challenge of AMR

The Academy of Medical Sciences is today (Friday, 13th October) announcing the pledge from The Yusuf and Farida Hamied Foundation1 for a scheme to build stronger research links between the UK and India to jointly address the challenge of antimicrobial resistance (AMR).

12 Oct 2017

Zika virus outbreak in Ecuador worsened by El Niño and 2016 earthquake

A Zika virus outbreak in coastal Ecuador in 2016 was likely worsened by a strong El Niño and a magnitude 7.8 earthquake that struck the region in April, according to a new study.

12 Oct 2017

WHO announces establishment of new high-level commission to tackle NCDs

Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, announced today the establishment of a new High-level global Commission on Noncommunicable Diseases (NCDs).

12 Oct 2017

World’s only Atomo HIV Self Test receives CE Marking from European Union Notified Body

Atomo Diagnostics, a world leader in innovative point-of-care, rapid diagnostic devices, announced today that its Atomo HIV Self Test has been granted CE Marking by a European Union Notified Body.

12 Oct 2017

Ebola vaccine that provides a year’s worth of protection developed

Liberia’s Ebola outbreak has yielded a successful trial of two vaccines against the deadly infection that could provide protection for up to a year and is also deemed to be safe.

12 Oct 2017

New research reveals negative consequences of coffee cultivation in Uganda

New research led by Kelly Austin, associate professor of sociology at Lehigh, explores unequal exchange in the coffee industry. She cites a range of negative consequences that coffee cultivation contributes to, including: malaria vulnerability, decreased participation in schooling, gender inequalities, and environmental degradation in Bududa, Uganda.

11 Oct 2017

Study reveals unique norovirus characteristic of hiding from host immune system

Noroviruses are the leading cause of non-bacterial gastroenteritis in the world and are estimated to cause 267 million infections and 20,000 deaths each year. This virus causes severe diarrhea, nausea, and stomach pain.

11 Oct 2017

Scientists better understand how rabies virus induces drastic changes in behavior

Scientists may finally understand how the rabies virus can drastically change its host's behavior to help spread the disease, which kills about 59,000 people annually.

11 Oct 2017

TB Alliance announces phase 1 clinical trials of two novel tuberculosis drugs

TBA-7371 and sutezolid entered phase 1 clinical trials, TB Alliance announced today. Both compounds have proceeded through early preclinical development and were granted "Investigative New Drug" status by the U.S. Food and Drug Administration. The phase 1 clinical trials are presently ongoing.

11 Oct 2017

New serotypes of Zika virus could appear in near future, researcher cautions

Zika virus is mutating so fast in Brazilian patients that different serotypes of the pathogen could appear in the near future, as is already the case with dengue virus. This would hinder the production of a vaccine and impair the effectiveness of the diagnostic tests already developed.

10 Oct 2017

Trial reveals value of tuberculosis chemoprophylaxis in HIV-infected people

Long-term follow-up in the ANRS TEMPRANO trial confirms that tuberculosis chemoprophylaxis in HIV-infected people is more than ever relevant in resource-limited countries.

10 Oct 2017